Tofacitinib 10 MG [Xeljanz]
Sponsors
Stanford University, McMaster University
Conditions
Diaphragm InjuryUlcerative Colitis Acute
Phase 2
Janus Kinase Inhibition to Prevent Ventilator-induced Diaphragm Dysfunction
RecruitingNCT03681275
Start: 2019-09-03End: 2026-11-30Target: 70Updated: 2024-11-25
Tofacitinib for Hospitalized Acute Severe Ulcerative Colitis Management
Active, not recruitingNCT04925973
Start: 2021-06-01End: 2023-12-31Updated: 2023-10-24